CD226 and prostate carcinoma: TGF-β1 probably causes the conversion of tumour-associated NK cells to a non-cytotoxic phenotype in prostate cancer by impairing NK cell receptor D (NKG2D) and DNAX accessory molecule-1 (DNAM-1) [83].